Business & Finance
06 February 2024, 9:40 pm 1 minute
Reuters exclusively reported that drug maker Novartis AG (NOVN.S) is in advanced talks to acquire MorphoSys AG (MORG.DE), a developer of cancer treatments that has a market value of 1.6 billion euros ($1.7 billion).
Market Impact
MorphoSys shares rose more than 40% on the news.
Article Tags
Topics of Interest: Business & Finance
Type: Reuters Best
Sectors: Pharmaceuticals & Healthcare
Regions: Europe
Win Types: Exclusivity
Story Types: Exclusive / Scoop
Media Types: Text
Customer Impact: Significant National Story